UTEC - The University of Tokyo Edge Capital Partners logo

UTEC - The University of Tokyo Edge Capital Partners

Asia, Tokyo, Japan, Tokyo

Description

UTEC (The University of Tokyo Edge Capital Partners) is a prominent deep-tech venture capital firm headquartered in Tokyo, Japan, with deep-rooted connections to leading academic and research institutions, most notably The University of Tokyo. Established with a core mission to bridge the gap between groundbreaking scientific discovery and commercial viability, UTEC specializes in early-stage investments in global deep-tech startups. Their investment philosophy is centered on "real tech" and "deep tech" across a broad spectrum of sectors, including artificial intelligence, biotechnology, healthcare, robotics, new materials, and quantum computing, aiming to transform fundamental research into impactful commercial enterprises.

UTEC is distinguished by its proactive and hands-on investment approach, frequently taking on the role of a lead investor. Beyond providing capital, the firm offers comprehensive support that encompasses strategic guidance, assistance with talent acquisition, and expert management of intellectual property. UTEC boasts a robust fundraising history, having successfully closed multiple funds. Their most recent fund, UTEC 6, finalized its closing in late 2023/early 2024, raising approximately ¥30 billion, which translates to over $200 million USD. This substantial capital base enables UTEC to provide sustained support to its portfolio companies through various growth phases, from seed to Series B and beyond, demonstrating significant follow-on investment capacity.

UTEC typically targets early-stage companies, with initial investments generally ranging from approximately $500,000 to $5,000,000 USD, tailored to the specific stage and capital requirements of the startup. The firm is prepared to commit substantial follow-on capital, potentially up to several tens of millions of dollars, to propel its most promising ventures through critical development milestones. With total assets under management exceeding ¥85 billion (over $570 million USD), UTEC has solidified its position as a pivotal entity within the global deep-tech ecosystem, actively fostering innovation and driving the commercialization of transformative technologies originating from academic research. Their portfolio showcases a strong track record of successful exits, including notable IPOs and strategic acquisitions, underscoring their expertise in identifying and nurturing high-potential deep-tech enterprises.

Investor Profile

UTEC - The University of Tokyo Edge Capital Partners has backed more than 50 startups, with 13 new investments in the last 12 months alone. The firm has led 19 rounds, about 38% of its total and boasts 19 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Seed rounds (top funding stages).
  • Majority of deals are located in United States, Japan, Singapore.
  • Strong thematic focus on Software, Medical, Biotechnology.
  • Led 5 rounds in the past year.
  • Typical check size: $500K – $5M.

Stage Focus

  • Series B (26%)
  • Series A (26%)
  • Seed (26%)
  • Series Unknown (18%)
  • Series C (2%)
  • Grant (2%)

Country Focus

  • United States (36%)
  • Japan (32%)
  • Singapore (14%)
  • United Kingdom (8%)
  • India (6%)
  • Switzerland (2%)
  • Kenya (2%)

Industry Focus

  • Software
  • Medical
  • Biotechnology
  • Health Care
  • Manufacturing
  • Analytics
  • Information Technology
  • Hardware
  • Battery
  • Artificial Intelligence (Ai)
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does UTEC - The University of Tokyo Edge Capital Partners frequently co-invest with?

TMV
North America, New York, United States, New York
Co-Investments: 2
Razor's Edge Ventures
North America, Virginia, United States, Reston
Co-Investments: 3
SMBC Venture Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 3
Blume Ventures
Asia, Maharashtra, India, Mumbai
Co-Investments: 3
Global Brain Corporation
Asia, Tokyo, Japan, Tokyo
Co-Investments: 3
Globis Capital Partners
Asia, Tokyo, Japan, Tokyo
Co-Investments: 3
Good Growth Capital
North America, South Carolina, United States, Charleston
Co-Investments: 3
B Capital
North America, California, United States, Manhattan Beach
Co-Investments: 3
Sony Innovation Fund
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 5

Which angels does UTEC - The University of Tokyo Edge Capital Partners often collaborate with?

Ramakant Sharma
Asia, Karnataka, India, Bengaluru
Shared Deals: 1
AJ
North America, California, United States, San Francisco
Shared Deals: 1
Sanjay Nath
Asia, Maharashtra, India, Mumbai
Shared Deals: 1
LS
North America, California, United States, San Francisco
Shared Deals: 1
LJ
Europe, Manchester, United Kingdom
Shared Deals: 1
Shared Deals: 1
NR
North America, California, United States, San Francisco
Shared Deals: 1
Kiran Mazumdar-Shaw
Asia, Karnataka, India, Bangalore
Shared Deals: 1
JJ
North America, California, United States, San Francisco
Shared Deals: 1
Prashant Pitti
Asia, Delhi, India, New Delhi
Shared Deals: 1

What are some of recent deals done by UTEC - The University of Tokyo Edge Capital Partners?

OptQC

Tokyo, Tokyo, Japan

OptQC is an IT firm that commercializes cutting-edge optical quantum computing technologies developed by the Furusawa-Endo Laboratory.

ComputerInternet of ThingsManufacturingQuantum Computing
Series AOct 22, 2025
Amount Raised: $9,869,281
CELLORB

Nishi, Tokyo, Japan

CELLORB provides player management, sports event planning, and event management services.

eSportsEvent ManagementFilm Production
Series UnknownOct 15, 2025
Amount Raised: $6,616,080
Celaid Therapeutics

Hongo, Tokyo, Japan

Celaid Therapeutics is a biotech company that develops cell therapies for blood cancer, intractable blood diseases, and genetic disorders.

BiotechnologyHealth CareManufacturingMedicalTherapeutics
Series BOct 7, 2025
Amount Raised: $3,653,876
Forest

Tokyo, Tokyo, Japan

Forest is a tech-driven e-commerce platform acquiring third-party brands, optimizing marketing via algorithm insights for growth.

E-CommerceMarketingSales
Series BOct 6, 2025
Amount Raised: $27,266,712
ROMS

Tokyo, Tokyo, Japan

ROMS is a technology company that provides planning, design, development, and sales of software, robotics, and automation systems.

Industrial AutomationInformation TechnologyRoboticsSoftware
Series UnknownSep 8, 2025
Amount Raised: $8,792,008

Pahr Therapeutics is a clinical stage business, is to create innovative ways to treat pulmonary arterial hypertension.

Clinical Trials
SeedJul 28, 2025
Amount Raised: $14,000,000
Alumnote

Tokyo, Tokyo, Japan

Alumnote develops online alumni association management platforms that enable schools to manage their alumni associations and alumni.

AlumniConsultingSaaS
Series AJul 22, 2025
Amount Raised: $5,147,290
Peach Cars

Nairobi, Nairobi Area, Kenya

Peach Cars is building a solution for those looking to buy and sell vehicles whole information on vehicles and hassle-free transactions.

Asset ManagementAutomotiveMarketplace
Series AJun 18, 2025
Amount Raised: $10,349,646
Forest

Tokyo, Tokyo, Japan

Forest is a tech-driven e-commerce platform acquiring third-party brands, optimizing marketing via algorithm insights for growth.

E-CommerceMarketingSales
Series BJun 4, 2025
Amount Raised: $13,306,306
Piece

Lugano, Ticino, Switzerland

Piece is a platform for investing in rented properties, offering monthly rental income and long-term appreciation for everyone.

FinTechReal EstateReal Estate Investment
SeedApr 21, 2025
Amount Raised: $3,143,311